 |
Delegates attending this course will benefit from
an introductory overview of the terminology and classification of
cancer and principle issues in its treatment. Commonly available
anti-cancer drugs will be reviewed with emphasis on mode of action,
dose intensity and chemotherapy regimes. The range of side effects
of chemotherapy treatment – both common and uncommon –
will be studied in detail. Quality of life issues in terms of overall
assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumor
types; breast, lung, upper gastrointestinal (GI), colorectal, ovarian,
prostate and skin cancer. Each session will be presented by clinicians
active in these areas and will focus on overall patient presentation
and management and cancer diagnosis and staging. Following these
sessions, our experts will lead delegates in interactive group discussions
on the key issues relating to effective management of each tumor
type.
The limitations of cytotoxic drugs currently available are well
known. For this reason delegates will find the course includes in-depth
discussions of new drug development and identification of new pharmacological
targets of particular interest and value. Clinical trial design
issues in early and randomised trials will also be covered.
Topics to be covered include:
-
Cancer: Terminology and classification
-
Introduction to anti-cancer drugs
-
Side effects of chemotherapy and radiotherapy
-
New developments in cancer therapy
-
Introduction to the major tumor types: Breast,
lung, colorectal, skin, ovarian, GI and prostate
-
Clinical trial issues in oncology
Faculty includes
Jeffrey Crawford MD
Duke University Medical Center, North Carolina
Maurie Markman MD
MD Anderson Cancer Center, Texas
Nancy Dawson MD
Georgetown University Hospital, Washington
Adil Daud MD
University of California, San Francisco
Alan Venook MD,
University of California, San Francisco
Top
|
|
|
Why not also buy a copy of our
PharmaEssentials
Guide to oncology
109 pages (PDF)
More information >>
|
|
Who should attend? |
|
Healthcare’s courses
are designed for both medical and non-medical staff within
the pharmaceutical industry. This course is suitable for clinical
research, medical information, regulatory affairs, biometrics
and strategic marketing personnel.
|
| |
|
Fees |
|
The registration fee is $4,169. This includes
lunch and refreshments throughout the day. Accommodation costs
are not included.
Delegates can register on-line or by completing the booking
form and returning it together with the appropriate payment
to Healthcare Education Services Limited.
Please retain a copy of the booking form for your records. |
| |
|
Venue / Accommodation |
|
Details of the venue will be supplied on
registration. |
| |
|
